# Lofexidine_Opioid_Withdrawal

The information reported here results from secondary analyses of data from clinical trials conducted by the National Institute on Drug Abuse (NIDA). Specifically, data from CSP-1020: A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal were included. NIDA databases and information are available at [http://datashare.nida.nih.gov](http://datashare.nida.nih.gov)
